低剂量阿司匹林削减患乳腺癌的风险为糖尿病妇女的

Study of women with diabetes showed a reduced breast cancer risk for women who used low-dose aspirin compared to those who did not.

A new study of nearly 149,000 women with diabetes over 14 years showed an overall 18% reduced breast cancer risk for women who used low-dose aspirin compared to those who did not.

The study design and results are published in an article in Journal of Women’s Health, 玛丽安 Liebert 同行评审的出版物, 公司, 出版商.

文章 上可用的免费 妇女杂志 ’ s 健康 website until July 8, 2017.

在一篇题为 “Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan,” Yi-Sun Yang, MD, 博士学位, Chien-Ning Huang, MD, 博士学位, and coauthors from Chung Shan Medical University Hospital and Hung Kuang University, Taichung, 台湾, defined low-dose aspirin use as intake of 75-165 mg daily.

The researchers reported that a high cumulative dose of aspirin over the 14-year study period reduced breast cancer risk by 47%, whereas low and medium cumulative doses did not reduce risk.

“妇女型 2 diabetes have an increased risk of breast cancer, and these results suggest that the same low-dose aspirin that many of these women take to prevent cardiovascular disease may also help reduce their risk of breast cancer,” 说苏珊 G. Kornstein, MD, 妇女杂志总编辑 ’ s 健康, 妇女弗吉尼亚英联邦大学研究所的执行主任 ’ s 健康, 里士满, VA, 和女子学院的院长 ’ s 健康.

信用: 玛丽安 Liebert, 公司, 出版商

评论这个故事